Dr. Hannes Cash began his medical career as a Resident Doctor at the Clinic for Urology, Charité – Universitätsmedizin Berlin, working under Prof. Dr. K. Miller from 2009 to 2014. Following this, he specialized in Urology at the same clinic until 2016. In 2014 and 2015, he served as a Visiting Scientist at the Max Planck Institute of Molecular Genetics, Core Sequencing Facility in Berlin, funded by the Eisenberger Scholarship of the German Society of Urology (DGU).
In 2017, Dr. Cash achieved his Habilitation with a focus on the implications of MRI/ultrasound fusion-guided targeted biopsies on the diagnostics of prostate cancer, earning Venia Legendi for the subject Urology at Charité – Universitätsmedizin Berlin. He continued his career as a Senior Physician at the Clinic for Urology, Charité, before taking on the role of Coordinator of the Prostate Cancer Center from 2016 to 2020.
From 2018 to September 2020, Dr. Cash served as the head of BPH laser therapy and imaging of the prostate, fusion biopsy, and focal therapy at the Clinic for Urology, Charité – Universitätsmedizin Berlin, under Prof. Dr. T. Schlomm.
In 2018, Dr. Cash’s group was the first to use 29 MHz high-resolution micro-ultrasound for the diagnostics of prostate cancer in Germany, and the group was among the first to publish data on the potential of this novel imaging modality.
In June 2020, Dr. Cash and Dr. Buckendahl founded the specialized practice ProUro Berlin in cooperation with MEOCLINIC.
The clinical focus is GreenLight laser treatment of benign prostatic hyperplasia (BPH), minimally invasive treatment of BPH with the REZÜM system, MRI, ultrasound fusion biopsy using micro-ultrasound.
Dr. Cash was involved in both planning and as local PI of the OPTIMUM trial comparing micro-ultrasound to MRI for prostate cancer detection, which was just published in JAMA.
Selected publications from PubMed
Optimizing prostate biopsy decision making - (MUSIC-screen): A 1:1 randomized controlled trial comparing micro-ultrasound versus multiparametric magnetic resonance imaging for prostate cancer diagnosis.
Guer M, Beksac AT, Brisbane W, Cash H, Ghai S, Ghosh S, Heinrichs A, Klotz L, Lavigueur-Blouin H, Löffeler S, Lughezzani G, Mannas M, Meng X, Morgan TN, Nahar B, Rodrigues T, Struck JP, Tiwari R, Toledano H, Urdaneta F, Kinnaird A
Contemp Clin Trials. 2026 Sep;168:108410 doi: 10.1016/j.cct.2026.108410.
External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial.
Lazarovich A, Guer M, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L, Kinnaird A
J Urol. 2026 Sep;216(3):352-359 doi: 10.1097/JU.0000000000005082.
Micro-ultrasound for prostate cancer.
Guer M, Brisbane WG, Cash H, Ghai S, Klotz L, Wilson PFR, Kinnaird A
Nat Rev Urol. 2026 May;23(5):309-318 doi: 10.1038/s41585-025-01111-w.
Response to correspondence regarding "The value of micro-ultrasound for prostate cancer screening: a retrospective real-world feasibility study".
Wendler JJ, Bechstein J, Cash H
Prostate Cancer Prostatic Dis. 2026 Oct;29(4):909-910 doi: 10.1038/s41391-026-01112-9.
The value of micro-ultrasound for prostate cancer screening: A retrospective real-world feasibility study.
Wendler JJ, Bechstein J, Buckendahl J, Kruck S, Samtleben C, Liehr BU, Porsch M, Cash H
Prostate Cancer Prostatic Dis. 2026 Oct;29(4):799-805 doi: 10.1038/s41391-026-01075-x.
Dr. Hannes Cash began his medical career as a Resident Doctor at the Clinic for Urology, Charité – Universitätsmedizin Berlin, working under Prof. Dr. K. Miller from 2009 to 2014. Following this, he specialized in Urology at the same clinic until 2016. In 2014 and 2015, he served as a Visiting Scientist at the Max Planck Institute of Molecular Genetics, Core Sequencing Facility in Berlin, funded by the Eisenberger Scholarship of the German Society of Urology (DGU). In 2017, Dr. Cash achieved his Habilitation with a focus on the implications of MRI/ultrasound fusion-guided targeted biopsies on the diagnostics of prostate cancer, earning Venia Legendi for the subject Urology at Charité – Universitätsmedizin Berlin. He continued his career as a Senior Physician at the Clinic for Urology, Charité, before taking on the role of Coordinator of the Prostate Cancer Center from 2016 to 2020. From 2018 to September 2020, Dr. Cash served as the head of BPH laser therapy and imaging of the prostate, fusion biopsy, and focal therapy at the Clinic for Urology, Charité – Universitätsmedizin Berlin, under Prof. Dr. T. Schlomm. In 2018 Dr. Cash’s group was the first du use 29MHz high resolution micro-ultrasound for the diagnostics of prostate cancer in Germany and the groups was among the first groups to publish data on the potential of this novel imaging modality. In June 2020, Dr. Cash and Dr. Buckendahl founded the specialized practice ProUro Berlin in cooperation MEOCLINIC. The clinical focus is Greenlight laser treatment of benign prostatic hyperplasia (BHP), minimally invasive treatment of BHP with the REZÜM system, MRI, ultrasound fusion biopsy using micro-ultrasound. Dr. Cash was involved in both planing and as local PI of the OPTIMUM trial comparing micro-ultrasound to MRI for prostate cancer detection, wich was just published in JAMA.
Published
Apr 2025
PD Dr. Hannes Cash (Germany) and his team at the Meoclinic Berlin (Germany) will perform a Greenlight Vapoenucleation of the prostate and answer all your questions.
With Boston Scientific
Published
Apr 2024
Help your network discover Dr. Hannes Cash's clinical expertise.
